Interleukin-25 negatively controls pathogenic responses in the gut.
Franzè, Eleonora
Interleukin-25 negatively controls pathogenic responses in the gut. [electronic resource] - Inflammation & allergy drug targets Jun 2011 - 187-91 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
2212-4055
10.2174/187152811795564028 doi
Animals
Colitis, Ulcerative--immunology
Crohn Disease--immunology
Feedback, Physiological
Humans
Immunity, Mucosal--drug effects
Immunologic Factors--pharmacology
Immunotherapy
Interleukin-17--immunology
Intestinal Mucosa--drug effects
Th1-Th2 Balance--drug effects
Th17 Cells--drug effects
Interleukin-25 negatively controls pathogenic responses in the gut. [electronic resource] - Inflammation & allergy drug targets Jun 2011 - 187-91 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
2212-4055
10.2174/187152811795564028 doi
Animals
Colitis, Ulcerative--immunology
Crohn Disease--immunology
Feedback, Physiological
Humans
Immunity, Mucosal--drug effects
Immunologic Factors--pharmacology
Immunotherapy
Interleukin-17--immunology
Intestinal Mucosa--drug effects
Th1-Th2 Balance--drug effects
Th17 Cells--drug effects